- Home
- PHVS vs XIFR Comparison
PHVS vs XIFR Comparison
Compare PHVS & XIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- XIFR
- Stock Information
- Founded
- PHVS 2015
- XIFR 2014
- Country
- PHVS Switzerland
- XIFR United States
- Employees
- PHVS N/A
- XIFR N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- XIFR
- Sector
- PHVS Health Care
- XIFR
- Exchange
- PHVS Nasdaq
- XIFR NYSE
- Market Cap
- PHVS 909.5M
- XIFR 874.5M
- IPO Year
- PHVS 2021
- XIFR N/A
- Fundamental
- Price
- PHVS $16.49
- XIFR $8.70
- Analyst Decision
- PHVS Strong Buy
- XIFR Sell
- Analyst Count
- PHVS 5
- XIFR 3
- Target Price
- PHVS $39.20
- XIFR $9.00
- AVG Volume (30 Days)
- PHVS 59.6K
- XIFR 1.2M
- Earning Date
- PHVS 05-13-2025
- XIFR 07-23-2025
- Dividend Yield
- PHVS N/A
- XIFR 20.95%
- EPS Growth
- PHVS N/A
- XIFR N/A
- EPS
- PHVS N/A
- XIFR N/A
- Revenue
- PHVS N/A
- XIFR $1,255,000,000.00
- Revenue This Year
- PHVS N/A
- XIFR $11.22
- Revenue Next Year
- PHVS N/A
- XIFR $1.90
- P/E Ratio
- PHVS N/A
- XIFR N/A
- Revenue Growth
- PHVS N/A
- XIFR 15.14
- 52 Week Low
- PHVS $11.51
- XIFR $7.53
- 52 Week High
- PHVS $25.50
- XIFR $34.05
- Technical
- Relative Strength Index (RSI)
- PHVS 51.83
- XIFR N/A
- Support Level
- PHVS $15.46
- XIFR N/A
- Resistance Level
- PHVS $16.99
- XIFR N/A
- Average True Range (ATR)
- PHVS 1.04
- XIFR 0.00
- MACD
- PHVS -0.08
- XIFR 0.00
- Stochastic Oscillator
- PHVS 71.48
- XIFR 0.00
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About XIFR XPLR INFRASTRUCTURE LP
NextEra Energy Partners LP is formed to acquire, manage, and own contracted clean energy projects. It owns interests in wind and solar projects in North America, as well as natural gas infrastructure assets in Texas. Renewable energy assets consist of wind, solar, and solar-plus-storage projects and a stand-alone battery storage project, as well as contracted natural gas pipeline assets. Renewable energy sales generate maximum revenue for the company.